Benzimidazole drugs and modulation of biotransformation enzymes
- 1 April 2004
- journal article
- review article
- Published by Elsevier BV in Research in Veterinary Science
- Vol. 76 (2), 95-108
- https://doi.org/10.1016/j.rvsc.2003.08.005
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Induction of cytochrome P450 enzymes by albendazole treatment in the ratEnvironmental Toxicology and Pharmacology, 2000
- Structural Requirements for the Induction of Cytochromes P450 by Benzimidazole Anthelmintic Derivatives in Cultured Rabbit HepatocytesBiochemical and Biophysical Research Communications, 1996
- Clinical Pharmacokinetics of LansoprazoleClinical Pharmacokinetics, 1995
- Induction of CYP2B1 mediated pentoxyresorufin O-dealkylase activity in different species, sex and tissue by prototype 2B1-inducersChemico-Biological Interactions, 1995
- Thiabendazole Is an Inducer of Cytochrome P4501A1 in Cultured Rabbit HepatocytesBiochemical and Biophysical Research Communications, 1994
- Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptorBiochemical and Biophysical Research Communications, 1992
- Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazoleDigestive Diseases and Sciences, 1991
- Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattleResearch in Veterinary Science, 1991
- Reaction of 1-amino- and 1-chlorophthalazine with mammalian molybdenum hydroxylasesin vitroXenobiotica, 1987
- Some Properties of the Sulphoxidases and Sulphoxide Reductases of the CestodeMoniezia Expansa, the NematodeAscaris Suumand Mouse LiverXenobiotica, 1979